Colin Evans

Dr. Colin Evans

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2016 in Nature
Verified
Journal Article
Open access
PDF file
PTPetros A. Tyrakis
Petros A. Tyrakis
APAsís Palazón
Asís Palazón
DMDavid Macias
David Macias
KLKian. L. Lee
Kian. L. Lee
APAnthony. T. Phan
Anthony. T. Phan
RJRandall S. Johnson
Randall S. Johnson
R-2-hydroxyglutarate accumulates to millimolar levels in cancer cells with gain-of-function isocitrate dehydrogenase 1/2 mutations. These levels of R-2-hydroxyglutarate affect 2-oxoglutarate-dependent dioxygenases. Both metabolite enantiomers, R- and S-2-hydroxyglutarate, are detectible in healthy individuals, yet their physiological function remains elusive. Here we show that 2-hydroxyglutarate accumulates in mouse CD8+ T cells in response to T-cell receptor triggering, and accumulates to millimolar levels in physiological oxygen conditions through a hypoxia-inducible factor 1-alpha (HIF-1α)-dependent mechanism. S-2-hydroxyglutarate predominates over R-2-hydroxyglutarate in activated T cells, and we demonstrate alterations in markers of CD8+ T-cell differentiation in response to this metabolite. Modulation of histone and DNA demethylation, as well as HIF-1α stability, mediate these effects. S-2-hydroxyglutarate treatment greatly enhances the in vivo proliferation, persistence and anti-tumour capacity of adoptively transferred CD8+ T cells. Thus, S-2-hydroxyglutarate acts as an immunometabolite that links environmental context, through a metabolic–epigenetic axis, to immune fate and function.

1 September 2019 in Thrombosis Research
Verified
Journal Article
Closed access
NGNeha Gupta
Neha Gupta
YZYouyang Zhao
Youyang Zhao
CEColin Evans
Colin Evans

28 January 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
WZWenting Zhang
Wenting Zhang
QHQinghua Huang
Qinghua Huang
WXWeiwei Xiao
Weiwei Xiao
YZYue Zhao
Yue Zhao
JPJiang Pi
Jiang Pi
HJHua Jin
Hua Jin
CD47 is an immunoglobulin that is overexpressed on the surface of many types of cancer cells. CD47 forms a signaling complex with signal-regulatory protein α (SIRPα), enabling the escape of these cancer cells from macrophage-mediated phagocytosis. In recent years, CD47 has been shown to be highly expressed by various types of solid tumors and to be associated with poor patient prognosis in various types of cancer. A growing number of studies have since demonstrated that inhibiting the CD47-SIRPα signaling pathway promotes the adaptive immune response and enhances the phagocytosis of tumor cells by macrophages. Improved understanding in this field of research could lead to the development of novel and effective anti-tumor treatments that act through the inhibition of CD47 signaling in cancer cells. In this review, we describe the structure and function of CD47, provide an overview of studies that have aimed to inhibit CD47-dependent avoidance of macrophage-mediated phagocytosis by tumor cells, and assess the potential and challenges for targeting the CD47-SIRPα signaling pathway in anti-cancer therapy.

1 January 2012 in Cancer Cell
Verified
Journal Article
Open access
CBCristina Branco-Price
Cristina Branco-Price
NZNa Zhang
Na Zhang
MSMoritz Schnelle
Moritz Schnelle
CEColin Evans
Colin Evans
DKDörthe M. Katschinski
Dörthe M. Katschinski
RJRandall S. Johnson
Randall S. Johnson
The hypoxia inducible transcription factors (HIFs) control many mediators of vascular response, including both angiogenic factors and small molecules such as nitric oxide (NO). In studying how endothelial HIF response itself affects metastasis, we found that loss of HIF-1α in endothelial cells reduces NO synthesis, retards tumor cell migration through endothelial layers, and restricts tumor cell metastasis, and that loss of HIF-2α has in each case the opposite effect. This results from differential regulation of NO homeostasis that in turn regulates vascular endothelial growth factor expression in an NO-dependent feedback loop. These opposing roles for the two HIF factors indicate that both they and endothelial cells regulate metastasis as malignancy progresses.

1 January 2021 in The American Journal of Pathology
Verified
Journal Article
Closed access
CEColin Evans
Colin Evans
MIM. Luisa Iruela-Arispe
M. Luisa Iruela-Arispe
YZYouyang Zhao
Youyang Zhao

1 March 2011 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
PSPrakash Saha
Prakash Saha
JHJulia Humphries
Julia Humphries
BMBijan Modarai
Bijan Modarai
KMKatherine Mattock
Katherine Mattock
MWMatthew Waltham
Matthew Waltham
ASAlberto Smith
Alberto Smith
Observational studies have shown that inflammatory cells accumulate within the thrombus and surrounding vein wall during the natural history of venous thrombosis. More recent studies have begun to unravel the mechanisms that regulate this interaction and have confirmed that thrombosis and inflammation are intimately linked. This review outlines our current knowledge of the complex relationship between inflammatory cell activity and venous thrombosis and highlights new areas of research in this field. A better understanding of this relationship could lead to the development of novel therapeutic targets that inhibit thrombus formation or promote its resolution.